Maze Share Price

Maze Share Price

NASDAQ: MAZE | Small Cap | Healthcare
$31.31
-$1.55 (-4.72%) Last updated on 19 Nov, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Maze Stock Performance

Open
$33.09
Prev. Close
$32.86
Circuit Range
N/A
Day Range
$31.12 - $33.37
Year Range
$21.98 - $53.60
Volume
29,979
Average Traded
$32.06

Maze Share Price Today

As of 19 November 2026, Maze Therapeutics, Inc.'s share price is $31.31. The stock opened at $33.09, compared to its previous close of $32.86. During today's trading session, Maze Therapeutics, Inc.'s share price traded between $31.12 and $33.37, with an average price of $32.24. Over the past 52 weeks, the stock has recorded a high of $53.60 and a low of $21.98. In terms of performance, Maze Therapeutics, Inc.'s share price has risen by 18.42% over the last six months and is down 17.11% on a year-on-year basis.

Maze Share Price Chart

Line chart of the Maze price trend over the selected period. The price fell overall, ranging from 31.12 to 33.53, ending at 31.18.
$31.12$33.37
L
Show Current Price
H

Maze Stock Fundamentals & Key Indicators

Market Cap
$1.35B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.77
Revenue (TTM)
$0.00
Return On Equity (TTM)
-35.35%
Profit Margin
N/A
Debt to Equity
0.09
Quarterly Earnings Growth YoY
-38.76%

Maze Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$20.00$0.00$0.00
Net Profit-$34.57-$24.21-$44.73-$47.97
Net Profit MarginN/A-121.05%N/AN/A
Income ChangeN/A29.97%-84.76%-7.24%

Maze Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.00
Net Profit-$131.12
Net Profit MarginN/A
Income ChangeN/A

Maze Balance Sheet

All figures in USD Million

Particulars2025
Non Current Assets47.41
Current Assets349.72
Total Assets397.13
Non Current Liabilities19.61
Current Liabilities22.56
Total Liabilities42.16
Shareholders' Equity354.97

Maze Cash Flow

Annually

All figures in USD Million

Particulars2025
Operating-111.94
Investing-170.96
Financing275.34

About Maze

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.

Maze Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$31.33
$31.18
-0.94%
Oct 2026
$27.14
$31.48
+15.74%
Sep 2026
$26.46
$27.20
-4.90%
Aug 2026
$26.00
$28.59
+6.22%
Jul 2026
$29.50
$26.92
-9.66%
Jun 2026
$25.82
$29.80
+12.71%
May 2026
$26.57
$26.44
-0.53%
Apr 2026
$30.89
$26.58
-10.72%
Mar 2026
$44.39
$29.77
-34.54%
Feb 2026
$43.59
$45.48
+4.29%
Jan 2026
$40.80
$43.61
+5.16%
Dec 2025
$37.44
$41.47
+9.78%

Maze Share Price FAQs